Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

More On QLT.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

QLT Inc. (QLT.TO)

-Toronto
2.59 Down 0.05(1.89%) Nov 30, 3:59PM EST
Prev Close:2.64
Open:2.69
Bid:2.45
Ask:2.60
1y Target Est:N/A
Beta:0.137814
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:2.31 - 2.70
52wk Range:1.60 - 4.00
Volume:5,150
Avg Vol (3m):5,192
Market Cap:136.83M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:28-Jun-13

Analysts

Annual EPS Est (Dec-16) :-0.73
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novelion Therapeutics Inc., a biopharmaceutical company, develops a portfolio of therapies for individuals living with rare diseases. Its product portfolio includes MYALEPT for the treatment of generalized lipodystrophy; JUXTAPID for treating homo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback